Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Psychopharmacology Bulletin|March 6, 2023
The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!Ahmed Naguy, Saxby Pridmore, Bibi AlamiriPsychopharmacology Bulletin|March 7, 2024
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with SchizophreniaAhmed Naguy, Saxby Pridmore, Bibi AlamiriCNS Spectrums|November 25, 2021
Sports psychiatry: a desideratum on sports arena!Ahmed Naguy, Saxby Pridmore, Bibi AlamiriAsian Journal of Psychiatry|October 3, 2022
Newly FDA-approved psychotropic medicationsAhmed Naguy, Saxby Pridmore, Bibi AlamiriClinical Neuropharmacology|August 30, 2021
Adjuvant Pitolisant in a Case With Early-Onset SchizophreniaAhmed Naguy, Saxby Pridmore, Bibi AlamiriPsychopharmacology Bulletin|June 10, 2026
Cariprazine for Autism-A Case ReportAhmed Naguy, Saxby Pridmore, Bibi AlamiriPsychopharmacology Bulletin|December 11, 2023
Treatment-Resistant Juvenile Depression-A Quicksand?Ahmed Naguy, Saxby Pridmore, Hessa Alhazeem, et al.Psychopharmacology Bulletin|June 20, 2022
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?Ahmed Naguy, Saxby Pridmore, Anubhuti Singh, et al.Psychopharmacology Bulletin|January 2, 2025
Psychopharmacology of Catatonia: A Tour D'horizonAhmed Naguy, Saxby Pridmore, Victoria Ozidu, et al.Psychopharmacology Bulletin|January 2, 2025
Early Positive Report of Viloxazine for a Child with Hyperkinetic AutismAhmed Naguy, Nadyah Alayadhi, Saxby Pridmore, et al.Pageof 16